Yanlu Xiong[Author] - Search Results

Year	Number of Results
2016	1
2017	3
2018	5
2019	1
2020	3
2021	6
2022	12
2023	8
2024	2

1

Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy.

Feng Y, Xiong Y, Qiao T, Li X, Jia L, Han Y. Feng Y, et al. Among authors: xiong y. Cancer Med. 2018 Dec;7(12):6124-6136. doi: 10.1002/cam4.1820. Epub 2018 Nov 6. Cancer Med. 2018. PMID: 30403008 Free PMC article. Review.

2

Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics.

Zhu J, Fan Y, Xiong Y, Wang W, Chen J, Xia Y, Lei J, Gong L, Sun S, Jiang T. Zhu J, et al. Among authors: xiong y. Exp Mol Med. 2022 Nov;54(11):2060-2076. doi: 10.1038/s12276-022-00896-9. Epub 2022 Nov 25. Exp Mol Med. 2022. PMID: 36434043 Free PMC article.

3

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer.

Shi AP, Tang XY, Xiong YL, Zheng KF, Liu YJ, Shi XG, Lv Y, Jiang T, Ma N, Zhao JB. Shi AP, et al. Front Immunol. 2022 Jan 17;12:785091. doi: 10.3389/fimmu.2021.785091. eCollection 2021. Front Immunol. 2022. PMID: 35111155 Free PMC article. Review.

4

Experimental mouse models for translational human cancer research.

Zhou Y, Xia J, Xu S, She T, Zhang Y, Sun Y, Wen M, Jiang T, Xiong Y, Lei J. Zhou Y, et al. Among authors: xiong y. Front Immunol. 2023 Mar 10;14:1095388. doi: 10.3389/fimmu.2023.1095388. eCollection 2023. Front Immunol. 2023. PMID: 36969176 Free PMC article. Review.

5

The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation.

Tang XY, Luo ZL, Xiong YL, Yang J, Shi AP, Zheng KF, Liu YJ, Shu C, Ma N, Lu Q, Zhao JB. Tang XY, et al. Cancers (Basel). 2022 Oct 31;14(21):5374. doi: 10.3390/cancers14215374. Cancers (Basel). 2022. PMID: 36358792 Free PMC article. Review.

6

Flexibility in metabolism bestows tenacious viability on cancer.

Xiong Y, Wang L, Feng Y, Li X, Jia L, Han Y. Xiong Y, et al. Life Sci. 2018 Sep 1;208:20-25. doi: 10.1016/j.lfs.2018.07.008. Epub 2018 Jul 6. Life Sci. 2018. PMID: 30146015 Review.

7

Recapitulating essential pathophysiological characteristics in lung-on-a-chip for disease studies.

Zhang Y, Wang X, Yang Y, Yan J, Xiong Y, Wang W, Lei J, Jiang T. Zhang Y, et al. Among authors: xiong y. Front Immunol. 2023 Feb 28;14:1093460. doi: 10.3389/fimmu.2023.1093460. eCollection 2023. Front Immunol. 2023. PMID: 36926347 Free PMC article. Review.

8

Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction.

Zuo B, Wang L, Li X, Li X, Wang J, Xiong Y, Lei J, Zhang X, Chen Y, Liu Q, Jiao J, Sui M, Fan J, Wu N, Song Z, Li G. Zuo B, et al. Among authors: xiong y. Aging (Albany NY). 2023 Nov 12;15(21):12451-12475. doi: 10.18632/aging.205191. Epub 2023 Nov 12. Aging (Albany NY). 2023. PMID: 37955668 Free PMC article.

9

Sirtuin 3: A Janus face in cancer (Review).

Xiong Y, Wang M, Zhao J, Han Y, Jia L. Xiong Y, et al. Int J Oncol. 2016 Dec;49(6):2227-2235. doi: 10.3892/ijo.2016.3767. Epub 2016 Nov 10. Int J Oncol. 2016. PMID: 27840909 Review.

10

IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy.

Tang XY, Xiong YL, Shi XG, Zhao YB, Shi AP, Zheng KF, Liu YJ, Jiang T, Ma N, Zhao JB. Tang XY, et al. Biomark Res. 2022 Jul 13;10(1):49. doi: 10.1186/s40364-022-00394-0. Biomark Res. 2022. PMID: 35831836 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year